Works matching DE "INVITROGEN Corp."
1
- Nature, 2009, v. 459, n. 7243, p. 19, doi. 10.1038/459019a
- Article
2
- Nature Genetics, 1999, v. 23, n. 4, p. 479, doi. 10.1038/70607
- Article
3
- PharmaGenomics, 2004, v. 4, n. 4, p. 19
- Article
4
- PharmaGenomics, 2003, v. 3, n. 1, p. 14
- Article
5
- Texas Law Review, 2010, v. 89, n. 2, p. 477
- Granaghan, Christopher G.
- Article
6
- Journal of Generic Medicines, 2006, v. 3, n. 3, p. 237, doi. 10.1057/palgrave.jgm.4940125
- Braier, Paul A.;
- Roylance, Stephen M.;
- Greenblum, Benjamin M.
- Article
7
- Journal of Generic Medicines, 2006, v. 3, n. 2, p. 161, doi. 10.1057/palgrave.jgm.4940114
- Browning, Jill M.;
- Brown, Rebecca A.;
- Greenblum, Benjamin
- Article
8
- Bio-IT World, 2008, v. 7, n. 9, p. 10
- Article
9
- Bio-IT World, 2008, v. 7, n. 6, p. 12
- Article
11
- Bio-IT World, 2005, v. 4, n. 8, p. 14
- Article
12
- Bio-IT World, 2005, v. 4, n. 7, p. 10
- Article
13
- Bio-IT World, 2004, v. 3, n. 6, p. 18
- Article
14
- Bio-IT World, 2004, v. 3, n. 1, p. 24
- Article
15
- Bio-IT World, 2003, v. 2, n. 12, p. 18
- Article
16
- Bio-IT World, 2003, v. 2, n. 10, p. 58
- Article
17
- Nature Reviews Drug Discovery, 2006, v. 5, n. 12, p. 1051, doi. 10.1038/nrd2198
- Article
18
- Pharmaceutical Discovery, 2005, v. 5, n. 9, p. 14
- Article
19
- Nature, 2002, v. 419, n. 6909, p. 767, doi. 10.1038/419767a
- Article
20
- Nature, 2002, v. 418, n. 6893, p. 109, doi. 10.1038/418109a
- Article
21
- Nature, 2001, v. 413, n. 6852, p. 233, doi. 10.1038/35093171
- Article
22
- Nature, 2001, v. 412, n. 6842, p. 101, doi. 10.1038/35083645
- Article
23
- Nature, 1999, v. 397, n. 6719, p. 541, doi. 10.1038/17416
- Article
24
- Nature, 2008, v. 453, n. 7198, p. 969, doi. 10.1038/453969f
- Article
25
- Nature, 2005, v. 438, n. 7068, p. 699, doi. 10.1038/438699a
- Article
26
- Nature, 2005, v. 435, n. 7044, p. 995, doi. 10.1038/435995a
- Article
27
- Nature, 2004, v. 432, n. 7019, p. 792, doi. 10.1038/432792a
- Article
28
- Nature, 2004, v. 431, n. 7008, p. 599, doi. 10.1038/431599b
- Article
29
- Nature, 2004, v. 429, n. 6990, p. 486, doi. 10.1038/nj6990-486b
- Article
30
- Nature, 2003, v. 426, n. 6963, p. 205, doi. 10.1038/426205a
- Article
31
- Nature, 2003, v. 424, n. 6947, p. 469, doi. 10.1038/424469a
- Article
32
- IIE Solutions, 2001, v. 33, n. 12, p. 12
- Article
33
- Nature Biotechnology, 2008, v. 26, n. 8, p. 847, doi. 10.1038/nbt0808-847c
- Article
35
- Nature Biotechnology, 2005, v. 23, n. 2, p. 159, doi. 10.1038/nbt0205-159
- Jia, Hepeng;
- Louët, Sabine
- Article
36
- Nature Biotechnology, 2005, v. 23, n. 1, p. 3, doi. 10.1038/nbt0105-3
- Article
37
- Nature Biotechnology, 2004, v. 22, n. 2, p. 141, doi. 10.1038/nbt0204-141
- Article
38
- Nature Biotechnology, 2000, v. 18, n. 11, p. 1221, doi. 10.1038/81241
- Article
39
- Nature Biotechnology, 2000, v. 18, n. 3, p. 356, doi. 10.1038/73833
- Article
40
- Nature Biotechnology, 1999, v. 17, p. 5, doi. 10.1038/4625
- Article
41
- Expert Review of Molecular Diagnostics, 2008, v. 8, n. 4, p. 366
- Article
42
- Biotechnology Progress, 2010, v. 26, n. 5, p. 1205, doi. 10.1002/btpr.430
- Wu, Wan-Yi;
- Gillies, Alison R.;
- Hsii, Judy F.;
- Contreras, Lydia;
- Oak, Seachol;
- Perl, Michael B.;
- Wood, David W.
- Article